BNP Paribas Financial Markets’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$383M Sell
792,380
-1,021,438
-56% -$271M 0.13% 124
2026
Q1
$199M Buy
1,813,818
+1,016,432
+127% +$145M 0.1% 205
2025
Q4
$133M Sell
797,386
-329,954
-29% -$55.2M 0.06% 301
2025
Q3
$221M Buy
1,127,340
+960,899
+577% +$158M 0.12% 154
2025
Q2
$15M Sell
166,441
-457,413
-73% -$36.1M 0.01% 1176
2025
Q1
$37.2M Sell
623,854
-192,765
-24% -$17.8M 0.02% 741
2024
Q4
$108M Buy
816,619
+798,062
+4,301% +$74.9M 0.06% 320
2024
Q3
$972K Sell
18,557
-6,090
-25% -$286K ﹤0.01% 2517
2024
Q2
$1.49M Buy
+24,647
New +$1.71M ﹤0.01% 2071

Other funds holding ALAB

BNP Paribas Financial Markets's ALAB Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Astera Labs (ALAB) stake by 56% in Q2 2026, selling an estimated $271M and leaving 792,380 shares worth $383M. The position accounts for 0.13% of the portfolio, ranked #124.

BNP Paribas Financial Markets first reported a position in ALAB in Q2 2024 and has held it in 9 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • BNP Paribas Financial Markets held 792,380 shares of Astera Labs worth $383M as of Q2 2026.
  • BNP Paribas Financial Markets sold 1,021,438 Astera Labs shares in Q2 2026, an estimated $271M.
  • Astera Labs made up 0.13% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #124 holding.
  • BNP Paribas Financial Markets first reported a position in Astera Labs in Q2 2024 and has held it in 9 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.